Salas SE, Jiménez TJP

Language: Spanish
References: 16
Page: 1-10
PDF size: 130.51 Kb.

ABSTRACT

Sarcomas represent a heterogeneous group of malignancies of mesenchymal origin that can arise from any anatomical site. Of soft tissue sarcomas, retroperitoneal sarcoma represents approximately 15-20%. They usually grow more than 20 cm and unlike epithelial solid tumors, retroperitoneal sarcomas infiltrate several larger viscera and neurovascular structures, so surgery is often of high complexity. Radiation therapy and chemotherapy play an adjuvant or neoadjuvant role, but surgery remains the basis of treatment for resectable retroperitoneal sarcomas.

REFERENCES

1. Wang J, Grignol V, Gronchi A, Luo C, Pollock R, Tseng W. Surgical management of retroperitoneal sarcoma and opportunities for global collaboration. Chin Clin Oncol. 2018;7(4):39-39. https://doi.org/10.21037/cco.2018.07.05

2. Quagliuolo V, Gronchi A. Current Treatment of Retroperitoneal Sarcomas. 1st Ed. Milano: Springer; 2019. https://doi.org/10.1007/978-88-470-3980-3_1

3. Porpiglia A, Sanjay R, Jeffrey F. Retroperitoneal Sarcomas. Surgical Clinics, 2016;4(96): 993- 1001.https://doi.org/10.1016/j.suc.2016.05.009

4. Anaya DA, Lahat G, Wang X, et al. Establishing prognosis in retroperitoneal sarcoma: a new histologybased paradigm. Ann Surg Oncol. 2009;16(3):667-75. https://doi.org/10.1245/s10434-008-0250-2

5. Gyorki D, Choong P, Slavin J, Henderson M. Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcoma. ANZ J Sur. 2017;88(4):274- 277.https://doi.org/10.1111/ans.14125

6. Tseng W, Seo H, Pollock R, Gronchi A. Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma. Am J Clin Oncol. 2017;117(1):7- 11.https://doi.org/10.1002/jso.24888

7. Messiou C, Moskovic E, Vanel D, Morosi C, Benchimol R, Strauss D et al. Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm. European Journal of Surgical Oncology. 2017;43(7):1191-1198. https://doi.org/10.1016/j.ejso.2016.10.032

8. Wang J, Grignol V, Gronchi A, Luo C, Pollock R, Tseng W. Surgical management of retroperitoneal sarcoma and opportunities for global collaboration. Chin Clin Oncol. 2018;7(4):39-39. https://doi.org/10.21037/cco.2018.07.05

9. Gladdy RA, Gupta A, Catton CN. Retroperitoneal Sarcoma: Fact, Opinion, and Controversy. Surg Oncol Clin N Am. 2016;25:697-711. https://doi.org/10.1016/j.soc.2016.05.003

10. Gronchi A. Extended surgery for retroperitoneal sarcoma: the key to maximizing the potential for cure and survival. Pro. Oncology (Williston Park). 2013;27:640e642.

11. Kirane A, Crago A. The importance of surgical margins in retroperitoneal sarcoma. J Surg Oncol. 2015;113(3):270-276.https://doi.org/10.1002/jso.24135

12. Cananzi F, Ruspi L, Sicoli F, Minerva E, Quagliuolo V. Did outcomes improve in retroperitoneal sarcoma surgery?. J Surg Oncol. 2019;28:96-102. https://doi.org/10.1016/j.suronc.2018.11.004

13. Bonvalot S, Gronchi A, Swallow C, Strauss D, Meeus P, van Coevorden F et al. STRASS (EORTC 62092): A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. Am J Clin Oncol. 2019;2019 37:15_suppl, 11001-11001. https://doi.org/10.1200/JCO.2019.37.15_suppl.11001

14. Fairweather M, Gonzalez R, Strauss D, Raut C. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018;117(1):33-41. https://doi.org/10.1002/jso.24919

15. Konofaos P, Spartalis E, Moris D, Athanasiou A, Dimitroulis D, Markakis C, Kostakis ID, Nikiteas N and Kouraklis G: Challenges in the surgical treatment of retroperitoneal sarcomas. Indian J Surg 78: 1-5, 2016. https://doi.org/10.1007/s12262-015-1292-x

16. MacNeill A, Miceli R, Strauss D, Bonvalot S, Hohenberger P, Van Coevorden F et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group. Cancer. 2017;123(11):1971-1978. https://doi.org/10.1002/cncr.30572